Nu-Med Plus (NUMD) Total Debt (QoQ) (2013 - 2021)
Nu-Med Plus (NUMD) Total Debt (QoQ) (2013 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.70 Mn | 1.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -92.54% |
| Sep 30, 2020 | 3.34% |
| Jun 30, 2020 | 2.88% |
| Mar 31, 2020 | 3.52% |
| Dec 31, 2019 | 3,780.13% |
| Sep 30, 2019 | -48.78% |
| Jun 30, 2019 | -31.71% |
| Mar 31, 2019 | -61.60% |
| Dec 31, 2018 | 63.82% |
| Sep 30, 2018 | -14.70% |
| Jun 30, 2018 | -12.27% |
| Mar 31, 2018 | -10.46% |
| Dec 31, 2017 | -9.07% |
| Sep 30, 2017 | -7.94% |
| Jun 30, 2013 | 48.32% |
| Mar 31, 2013 | 101.56% |